Hamada M, Varkoly K, Riyadh O, Beladi R, Munuswamy-Ramanujam G, Rawls A
Biomedicines. 2024; 12(6).
PMID: 38927374
PMC: 11201033.
DOI: 10.3390/biomedicines12061167.
Gagnon K, Huang J, Hix O, Hui V, Hinds A, Bullitt E
APL Bioeng. 2024; 8(2):026126.
PMID: 38911024
PMC: 11191334.
DOI: 10.1063/5.0207228.
Penkov D, Beloglazova I, Parfyonova Y
Curr Pharm Des. 2024; 30(21):1630-1640.
PMID: 38715331
DOI: 10.2174/0113816128296376240424072322.
Chu X, Li W, Hines M, Lyakhov I, Mellors J, Dimitrov D
Front Oncol. 2023; 13:1194972.
PMID: 37876962
PMC: 10593477.
DOI: 10.3389/fonc.2023.1194972.
Georgieva I, Tchekalarova J, Iliev D, Tzoneva R
Int J Mol Sci. 2023; 24(14).
PMID: 37511104
PMC: 10379128.
DOI: 10.3390/ijms241411344.
The uPA/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis Progression.
Kanno Y
Int J Mol Sci. 2023; 24(2).
PMID: 36675310
PMC: 9866279.
DOI: 10.3390/ijms24021796.
Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation.
Elwan A, Abdallah A, Mahdy H, Dahab M, Taghour M, Elkaeed E
Molecules. 2022; 27(15).
PMID: 35956997
PMC: 9370530.
DOI: 10.3390/molecules27155047.
Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.
Alfano D, Franco P, Stoppelli M
Front Cell Dev Biol. 2022; 10:818616.
PMID: 35493073
PMC: 9045800.
DOI: 10.3389/fcell.2022.818616.
Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.
Zhai B, Tian H, Sun J, Zou J, Zhang X, Cheng J
J Transl Med. 2022; 20(1):135.
PMID: 35303878
PMC: 8932206.
DOI: 10.1186/s12967-022-03329-3.
New Series of VEGFR-2 Inhibitors and Apoptosis Enhancers: Design, Synthesis and Biological Evaluation.
Abdallah A, Mabrouk R, Elnagar M, Farrag A, Kalaba M, Sharaf M
Drug Des Devel Ther. 2022; 16:587-606.
PMID: 35281317
PMC: 8904266.
DOI: 10.2147/DDDT.S344750.
Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer.
Masucci M, Minopoli M, Di Carluccio G, Motti M, Carriero M
Cancers (Basel). 2022; 14(3).
PMID: 35158766
PMC: 8833673.
DOI: 10.3390/cancers14030498.
The essential anti-angiogenic strategies in cartilage engineering and osteoarthritic cartilage repair.
Pei Y, Chen S, Pei M
Cell Mol Life Sci. 2022; 79(1):71.
PMID: 35029764
PMC: 9805356.
DOI: 10.1007/s00018-021-04105-0.
The Blood-Brain Barrier, an Evolving Concept Based on Technological Advances and Cell-Cell Communications.
Menaceur C, Gosselet F, Fenart L, Saint-Pol J
Cells. 2022; 11(1).
PMID: 35011695
PMC: 8750298.
DOI: 10.3390/cells11010133.
The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis.
Anwar Ismail A, Shaker B, Bajou K
Int J Mol Sci. 2022; 23(1).
PMID: 35008762
PMC: 8745544.
DOI: 10.3390/ijms23010337.
uPAR: An Essential Factor for Tumor Development.
Lv T, Zhao Y, Jiang X, Yuan H, Wang H, Cui X
J Cancer. 2021; 12(23):7026-7040.
PMID: 34729105
PMC: 8558663.
DOI: 10.7150/jca.62281.
The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications.
Li Santi A, Napolitano F, Montuori N, Ragno P
Int J Mol Sci. 2021; 22(8).
PMID: 33923400
PMC: 8073738.
DOI: 10.3390/ijms22084111.
Effects of IL-1β and TNF-α on the Expression of P311 in Vascular Endothelial Cells and Wound Healing in Mice.
Zhou D, Liu T, Wang S, He W, Qian W, Luo G
Front Physiol. 2020; 11:545008.
PMID: 33329015
PMC: 7729022.
DOI: 10.3389/fphys.2020.545008.
Tubulin carboxypeptidase activity of vasohibin-1 inhibits angiogenesis by interfering with endocytosis and trafficking of pro-angiogenic factor receptors.
Kobayashi M, Wakabayashi I, Suzuki Y, Fujiwara K, Nakayama M, Watabe T
Angiogenesis. 2020; 24(1):159-176.
PMID: 33052495
DOI: 10.1007/s10456-020-09754-6.
COVID-19 and pneumonia: a role for the uPA/uPAR system.
DAlonzo D, De Fenza M, Pavone V
Drug Discov Today. 2020; 25(8):1528-1534.
PMID: 32562843
PMC: 7299864.
DOI: 10.1016/j.drudis.2020.06.013.
Elements of the Endomucin Extracellular Domain Essential for VEGF-Induced VEGFR2 Activity.
Hu Z, Cano I, Saez-Torres K, LeBlanc M, Saint-Geniez M, Ng Y
Cells. 2020; 9(6).
PMID: 32517158
PMC: 7349057.
DOI: 10.3390/cells9061413.